What does EMH mean in VETERINARY


Extramedullary Hematopoiesis (EMH) is a medical term used to describe the process in which immature blood cells form outside of the bone marrow. It occurs when the body's normal production of blood cells in the bone marrow is insufficient, and is a sign that something is wrong with your body's hematopoietic system. EMH can be seen in many health conditions and diseases, such as cancer, autoimmune diseases, and anemia.

EMH

EMH meaning in Veterinary in Medical

EMH mostly used in an acronym Veterinary in Category Medical that means Extramedullary Hematopoiesis

Shorthand: EMH,
Full Form: Extramedullary Hematopoiesis

For more information of "Extramedullary Hematopoiesis", see the section below.

» Medical » Veterinary

What Is Extramedullary Hematopoiesis?

EMH indicates the growth of red blood cells or platlets outside of the bone marrow. Normally, hematopoiesis happens within the bone marrow only. When not enough of these mature cells are produced there, some of them will migrate to other organs or tissues in order to find an external source to continue maturing. They will typically move to sites like the spleen, lymph nodes, thymus gland and liver. The immature cells will start their maturation process at these new sites and eventually develop into fully formed red blood cells or platlets. In some cases, those affected may experience difficulty producing white blood cells as well, due to EMH taking up resources from the bone marrow that would normally produce them.

Signs Of Extramedullary Hematopoiesis

In some people with EMH, few to no signs or symptoms may be present at all; however in more severe cases certain tell-tale indicators can occur. These can include fatigue due to elevated red cell counts, difficulties breathing due to unprocessed red cell wastes called “methemoglobin” showing up in circulation along with platelet clots causing blocked arteries leading to chest pain. Other common issues associated with EMH include swelling due increased fluid retention as well as low hemoglobin levels leading petechiae - small pinpoint purple/red spots on your skin caused by capillary bleeding - due decreased oxygen carrying capacity of circulating red blood cells.

Essential Questions and Answers on Extramedullary Hematopoiesis in "MEDICAL»VET"

What is Extramedullary Hematopoiesis?

Extramedullary Hematopoiesis (EMH) is a process of blood cell production that occurs outside of the bone marrow. It is a rare and complex phenomenon, which is usually associated with severe bone marrow failure.

What are the causes of Extramedullary Hematopoiesis?

EMH can be caused by a number of different medical conditions, including myelofibrosis, chronic myelogenous leukemia, lymphoma, and aplastic anemia. It can also be caused by long-term radiation or chemotherapy treatments for those disorders.

How does Extramedullary Hematopoiesis develop?

EMH is thought to develop when there is an inadequate amount of normal functioning hematopoietic tissue in the patient's bone marrow. The body then compensates for this deficiency by producing additional red blood cells, white blood cells and platelets outside of the bone marrow in other organs like the spleen or liver.

Who is at risk for developing Extramedullary Hematopoiesis?

Patients who have certain genetic disorders or have been treated with chemotherapy are more likely to develop EMH than those without these predisposing factors. People with myelodysplastic syndrome are particularly prone to developing EMH due to their abnormally low amounts of normal functioning hematopoietic tissue in the bone marrow.

What are some signs and symptoms related to Extramedullary Hematopoiesis?

Common signs and symptoms associated with EMH include fatigue, shortness of breath, jaundice, abdominal pain, loss of appetite and swelling in the abdomen or extremities. In some cases patients may experience organ failure as a result of overproduction of red blood cells and platelets in other organs like the liver or spleen resulting from EMH.

Are there any tests used to diagnose Extramedullary Hematopoiesis?

Yes, tests that may be used to diagnose EMH include complete blood counts (CBCs), CT scans or MRI scans to look at internal organs where hematopoietic tissue might be forming outside the bone marrow and biopsies on tissue samples taken from those organs.

Are there any treatment options available for Extramedullary Hematopoiesis?

Treatment options will vary depending on the underlying cause of EMH as well as individual patient factors like age and health status. Common treatment methods include chemotherapy drugs specifically designed to target cancerous tissues involved with EMH as well as hormone replacement therapy if necessary. In some cases organ transplantation may be needed if organ failure has occurred due to overproduction from extramedullary hematopoietic tissue in other organs.

Final Words:
Extramedullary Hematopoiesis (EMH) is a condition that occurs when production of red and white blood cells shifts from occurring primarily in the bone marrow to happening outside it instead — creating an imbalance that needs corrected before further complications can arise from it damaging other parts of the body it spreads into. While certain indicators such as fatigue or petechiae could indicate its presence — sometimes there are few if any symptoms present so regular checkups are important for ensuring your bodies functions remain healthy and balanced!

EMH also stands for:

All stands for EMH

Citation

Use the citation below to add this abbreviation to your bibliography:

Style: MLA Chicago APA

  • "EMH" www.englishdbs.com. 27 Dec, 2024. <https://www.englishdbs.com/abbreviation/260296>.
  • www.englishdbs.com. "EMH" Accessed 27 Dec, 2024. https://www.englishdbs.com/abbreviation/260296.
  • "EMH" (n.d.). www.englishdbs.com. Retrieved 27 Dec, 2024, from https://www.englishdbs.com/abbreviation/260296.
  • New

    Latest abbreviations

    »
    G
    Georgia Association of Licensed Adoption Agencies
    S
    Socorro Independent School District
    T
    Thank God For Family
    P
    Platform Enabled Training Capability
    W
    What The Future